+91 22 24172311
Sections
Search
Subscribe
Equity
Venture Capital
Private Equity
M&A

Mergers & Acquisitions | 3 August 2012

Sun Pharma To Acquire German Drug Maker Stada

by Vivek Singh
Sun Pharma To Acquire German Drug Maker Stada
Share on Social Media Email Facebook Twitter Linkedin
 
@vivek

Sun Pharmaceutical is planning acquisitions in Europe and is in talks with German drug maker Stada Arzneimittel AG.

The overseas acquisition is a part of strategic move to broaden its geographic breadth. Sun Pharma has followed a strategy of acquiring under-performing or unprofitable companies and merging their operations to its company.

The company is planning to raise $1 Bn for the acquisitions as the market value of the German drug maker is around $1.7 Bn. Sun Pharma has about $927 Mn cash on its balance sheet.

Hero MotoCorp Invests In Erik Buell Racing of U.S

Hero MotoCorp Invests In Erik Buell Racing of U.S

Hero MotoCorp Limited invested $20 Mn in American racing company Erik Buell Racing (EBR).

Read More...

Milestone Capital To Exit Maiden Bullion Fund

Milestone Capital To Exit Maiden Bullion Fund

Milestone Capital is planning to completely exit its maiden bullion fund - Milestone Bullion Series I by next month.

Read More...
CONTACT US
Info@DealCurry.com
+91 22 24172311
A 311, 3rd Floor, AntopHill Warehousing Company,
Near Dosti Acres
Wadala(E),
Mumbai 400037
   
 
CLIENTS
USEFUL LINKS
SOLUTIONS
Copyright © EagleEye Research & Media Pvt. Ltd. 2009 All Rights Reserved - Interactive multimedia analysis platform for financial markets.
Site map |Terms of Use |Privacy Policy
DealCurry tracks financial and corporate markets for events, interprets and integrates the information in our platform, providing premium data, news and analytics. DealCurry provides comprehensive coverage of the capital markets through an intuitive, user-friendly interface.